Pneumococcal conjugate second or third-dose vaccines (PCVc) in Belize
Belize: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 75.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Belize, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Belize stood at 75.0%. That is the highest value across all 18 years on record.
The figure is up 92.3% on the previous year.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Belize peaked at 75.0% in 2025 and was at its lowest, 0.0%, in 2008.
That places Belize 130th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Belize, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 0.0% | — |
| 2022 | 0.0% | — |
| 2023 | 0.0% | — |
| 2024 | 39.0% | — |
| 2025 | 75.0% | +92.3% |
Belize compared with similar countries
- Belize's 75.0% is below the median for upper middle income countries, which is 76.0%, 99% of the median. (57 countries reporting)
- Belize's 75.0% is below the median for Latin America & Caribbean, which is 82.5%, 91% of the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 19.0% | 0.0% | 75.0% | 6 |
Countries ranked near Belize
More health data for Belize
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5114 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,415 deaths per 1,000 people (2090)
- Number of infants who die before age 1 9 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.566 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0412 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.6604 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Belize?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Belize was 75.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Belize?
- The highest recorded value was 75.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Belize?
- The lowest recorded value was 0.0% in 2008.
- How does Belize rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Belize ranks 130th out of 194 countries with data for 2025.
- Where does this Belize data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).